Enliven Therapeutics, Inc. (ELVN) Insider Ownership

Historic Insider Ownership Trends

ELVN's three largest insider shareholders as of April 28, 2026 are Rishi Gupta (Director, 8.66Mn shares), Rishi Gupta (Director, 7.66Mn shares), Partners Vi, Llc 5am (TenPercentOwner, 4.31Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Rishi Gupta - 0 8,663,349 19 May, 2023
Rishi Gupta - 0 7,663,349 20 May, 2024
Partners Vi, Llc 5Am - 0 4,306,179 28 Sep, 2023
Partners Vi, Llc 5Am - 0 4,306,179 28 Sep, 2023
Partners Vi, Llc 5Am - 0 4,306,179 28 Sep, 2023
Partners Vi, Llc 5am - 0 4,306,179 28 Sep, 2023
Partners Vi, Llc 5Am - 0 4,306,179 28 Sep, 2023
Partners Vi, Llc 5Am - 0 4,306,179 28 Sep, 2023
David P Bonita - 0 4,199,068 23 Jul, 2021
Partners Vi, Llc 5Am - 0 3,835,975 16 Feb, 2024
Partners Vi, Llc 5Am - 0 3,835,975 16 Feb, 2024
Partners Vi, Llc 5am - 0 3,835,975 16 Feb, 2024
Partners Vi, Llc 5Am - 0 3,835,975 16 Feb, 2024
Partners Vi, Llc 5Am - 0 3,835,975 16 Feb, 2024
Partners Vi, Llc 5Am - 0 3,835,975 16 Feb, 2024
Enterprise Associates 14, L.P. New - 2,611,050 0 07 Apr, 2022
Enterprise Associates 14, L.P. New - 2,611,050 0 07 Apr, 2022
Enterprise Associates 14, L.P. New - 2,611,050 0 07 Apr, 2022
Enterprise Associates 14, L.P. New - 2,611,050 0 07 Apr, 2022
Enterprise Associates 14, L.P. New - 2,611,050 0 07 Apr, 2022
Enterprise Associates 14, L.P. New - 2,611,050 0 07 Apr, 2022
Enterprise Associates 14, L.P. New - 2,611,050 0 07 Apr, 2022
Mark Chin - 0 2,344,072 27 Jul, 2021
Braden Michael Leonard - 0 1,767,774 05 Jan, 2023
Braden Michael Leonard - 0 1,767,774 05 Jan, 2023
Capital Lp Commodore - 0 1,448,640 27 Feb, 2023
Andrew J. Schwab - 0 960,383 27 Feb, 2023
Andrew J. Schwab - 0 960,383 27 Feb, 2023
Samuel Kintz President And Ceo 0 890,392 19 Nov, 2025
Samuel Kintz President And Ceo 0 890,392 19 Nov, 2025
Joseph P Lyssikatos Chief Scientific Officer 0 740,188 10 Feb, 2026
Joseph P Lyssikatos Chief Scientific Officer 0 740,188 10 Feb, 2026
Rishi Gupta - 0 288,114 27 Feb, 2023
Braden Michael Leonard - 230,000 0 30 Dec, 2022
Braden Michael Leonard - 230,000 0 30 Dec, 2022
David M Mott - 229,224 0 23 Feb, 2022
Anish Patel Chief Operating Officer 0 215,011 13 Jan, 2026
Anish Patel Chief Operating Officer 0 215,011 13 Jan, 2026
Richard A. Heyman - 123,673 0 22 Oct, 2024
Richard A. Heyman - 123,673 0 22 Oct, 2024
Jake Bauer - 87,372 0 27 Feb, 2023
Benjamin Hohl Chief Financial Officer 51,000 0 10 Mar, 2026
Benjamin Hohl Chief Financial Officer 51,000 0 10 Mar, 2026
Kenneth Attie Svp, Cmo 34,100 0 01 Feb, 2022
Lori Anne Kunkel - 30,712 0 19 Dec, 2025
Michael Gray Cfo Coo 27,610 0 22 Feb, 2023
Helen Louise Collins Chief Medical Officer 25,000 0 21 Apr, 2026
Richard A. Heyman - 0 22,647 19 Feb, 2026
Richard A. Heyman - 0 22,647 19 Feb, 2026
Rahul D. Ballal Chief Executive Officer 22,341 0 10 Oct, 2024
Anish Patel Chief Operating Officer 20,000 0 17 Feb, 2026
Anish Patel Chief Operating Officer 20,000 0 17 Feb, 2026
Joseph P Lyssikatos Chief Scientific Officer 18,750 0 17 Feb, 2026
Joseph P Lyssikatos Chief Scientific Officer 18,750 0 17 Feb, 2026

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
17 Apr, 2026 Helen Louise Collins Common Stock A 5,000 $2.48 30,000 D M
17 Apr, 2026 Helen Louise Collins Common Stock D 140 $45.81 29,860 D S
17 Apr, 2026 Helen Louise Collins Common Stock D 2,419 $47.39 27,441 D S
17 Apr, 2026 Helen Louise Collins Common Stock D 2,441 $48.06 25,000 D S
17 Apr, 2026 Helen Louise Collins Stock Option (right to buy) D 5,000 $0.00 131,268 D M
25 Mar, 2026 Helen Louise Collins Common Stock A 40,000 $2.48 65,000 D M
25 Mar, 2026 Helen Louise Collins Common Stock D 40,000 $35.10 25,000 D S
25 Mar, 2026 Helen Louise Collins Stock Option (right to buy) D 40,000 $0.00 136,268 D M
17 Mar, 2026 Helen Louise Collins Common Stock A 5,000 $2.48 30,000 D M
17 Mar, 2026 Helen Louise Collins Common Stock D 5,000 $27.76 25,000 D S
17 Mar, 2026 Helen Louise Collins Stock Option (right to buy) D 5,000 $0.00 176,268 D M
09 Mar, 2026 Helen Louise Collins Common Stock A 29,871 $2.48 54,871 D M
09 Mar, 2026 Helen Louise Collins Common Stock D 29,871 $30.02 25,000 D S
10 Mar, 2026 Helen Louise Collins Common Stock A 10,129 $2.48 35,129 D M
10 Mar, 2026 Helen Louise Collins Common Stock D 10,129 $30.19 25,000 D S
09 Mar, 2026 Helen Louise Collins Stock Option (right to buy) D 29,871 $0.00 191,397 D M
10 Mar, 2026 Helen Louise Collins Stock Option (right to buy) D 10,129 $0.00 181,268 D M
06 Mar, 2026 Benjamin Hohl Common Stock D 10,000 $29.58 51,000 D S
06 Mar, 2026 Benjamin Hohl Common Stock D 10,000 $29.58 51,000 D S
17 Feb, 2026 Richard A. Heyman Common Stock D 1,230 $26.18 22,647 I S